The landmark study that prompted millions of women to stop taking combined hormone therapy resulted in $37.1 billion net economic return, thousands of lives saved, a new study finds
Fred Hutchinson Cancer Research Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers